A group of Democratic senators are calling on Health and Human Services Secretary Robert F. Kennedy Jr. to keep a proposed ...

The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage of anti-obesity drugsThe Trump administration says it will ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the government-funded Medicare program.

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...

The Centers for Medicare and Medicaid Services did ... in a statement that it may consider future policy options for anti-obesity medications “pending further review of both the potential ...

The previous administration attempted to have Medicare Part D and Medicaid cover anti-obesity drugs under the Contract Year 2026 MA and Part D rule, which would have substantially increased access ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...

The Biden administration sought to sidestep this obstacle by issuing a rule in November reinterpreting existing statutes to allow for Medicare Part D to cover anti-obesity drugs. But earlier this ...